Evidence map›Paper›PMID 19144123›Full record

ArticleBMC pharmacology2009

Conformational changes in alpha 7 acetylcholine receptors underlying allosteric modulation by divalent cations.

James T McLaughlin, Sean C Barron, Jennifer A See, Robert L Rosenberg

Open access · hybridAbstract read
In one paragraph

Article in BMC pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Mechanism of Allosteric Modulation of the Cys-loop Receptors.Pharmaceuticals (Basel, Switzerland) · 2010
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

James T McLaughlinDepartment of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA. jmclaughlin@unc.edu
Sean C Barron
Jennifer A See
Robert L Rosenberg
University of North Carolina at Chapel Hill · US

Funding

Agonist-driven conformational changes in nAChRsR01DA017882 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MCLAUGHLIN, JAMES · 2004 to 2008
$1.4M
NIDA NIH HHS DA017882NIDA NIH HHS R01 DA017882
6 · The paper itself

Abstract

Allosteric modulation of membrane receptors is a widespread mechanism by which endogenous and exogenous agents regulate receptor function. For example, several members of the nicotinic receptor family are modulated by physiological concentrations of extracellular calcium ions. In this paper, we examined conformational changes underlying this modulation and compare these with changes evoked by ACh. Two sets of residues in the alpha 7 acetylcholine receptor extracellular domain were mutated to cysteine and analyzed by measuring the rates of modification by the thiol-specific reagent 2-aminoethylmethane thiosulfonate. Using Ba2+ as a surrogate for Ca2+, we found a divalent-dependent decrease the modification rates of cysteine substitutions at M37 and M40, residues at which rates were also slowed by ACh. In contrast, Ba2+ had no significant effect at N52C, a residue where ACh increased the rate of modification. Thus divalent modulators cause some but not all of the conformational effects elicited by agonist. Cysteine substitution of either of two glutamates (E44 or E172), thought to participate in the divalent cation binding site, caused a loss of allosteric modulation, yet Ba2+ still had a significant effect on modification rates of these residues. In addition, the effect of Ba2+ at these residues did not appear to be due to direct occlusion. Our data demonstrate that modulation by divalent cations involves substantial conformational changes in the receptor extracellular domain. Our evidence also suggests the modulation occurs via a binding site distinct from one which includes either (or both) of the conserved glutamates at E44 or E172.

Indexed as

Protein ConformationAcetylcholineAllosteric RegulationAllosteric SiteAmino Acid SubstitutionAnimalsBariumCalciumCations, DivalentCysteineDose-Response Relationship, DrugMembrane PotentialsMutagenesis, Site-DirectedOocytesPeptide FragmentsProtein BindingAcetylcholineacetylcholine receptor alpha-subunit (125-148)BariumCalciumCations, DivalentCysteinePeptide FragmentsReceptors, Nicotinic

Identifiers

PMID19144123
PMCPMC2632993
OpenAlexW1990327988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.